Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

34.47 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Operating Activities:
Net Income -298.408-214.529-163.918-107.641-73.812-50.422-27.115-9.157-6.019
Depreciation & Amortization 2.7851.0980.9830.9220.9480.8870.4710.1280.092
Deferred Income Tax 0-28.48500.422-0.227-1.229000
Stock Based Compensation 69.38640.93728.26817.35210.4276.2942.320.2710.27
Change In Working Capital 11.6358.04418.6121.0960.376-2.1335.298-0.7210.189
Accounts Receivables 17.54114.64810.9946.2932.7230000
Inventory 000-6.293-2.7230000
Accounts Payables 0010.9946.2932.7230.6967.3610.0470.3
Other Working Capital -5.906-6.604-3.376-5.197-2.347-2.829-2.063-0.768-0.111
Other Non Cash Items -11.36826.6280.85-0.7390.2610.222-0.4330.480.154
Operating Cash Flow -225.97-166.307-115.205-88.588-62.027-46.381-19.459-9.479-5.468
Investing Activities:
Investments In Property Plant And Equipment -3.844-4.688-1.656-0.436-0.186-0.492-1.059-0.304-0.19
Acquisitions Net 0195.7250.0340.422-0.227-1.229000
Purchases Of Investments -1,161.703-532.857-329.817-125.404-135.592-108.136-118.39900
Sales Maturities Of Investments 575.799337.132157.49369.357135.995150.295000
Other Investing Activites 14.931-195.725-0.034-0.4220.2271.229-118.39900
Investing Cash Flow -574.817-200.413-173.98-56.4830.21741.667-119.458-0.304-0.19
Financing Activities:
Debt Repayment 0000000-0.212-0.048
Common Stock Issued 970.048369.019117.242249.542114.2830106.47212.0350
Common Stock Repurchased 00000-0.05900-0.005
Dividends Paid 000000000
Other Financing Activities 40.38719.9254.7213.1370.2880.12663.72612.035-0.01
Financing Cash Flow 1,010.435388.944121.963252.679114.5710.067170.19811.823-0.053
Other Information:
Effect Of Forex Changes On Cash 000000000
Net Change In Cash 209.64822.224-167.222107.60852.761-4.64731.2812.04-5.711
Cash At End Of Period 265.84556.19733.973201.19593.58740.82645.47314.19212.152